Sierk Poetting

Dr. Sierk Poetting is Chief Operating Officer at BioNTech. Dr. Poetting joined us in September 2014 from Novartis, where he held various positions and served as Vice President and Chief Financial Officer for the Sandoz Division in North America from May 2012 to August 2014. Dr. Poetting began his career as a consultant with McKinsey & Company. Sierk Poetting is a German citizen and holds a Master of Science in Optical Sciences from the University of Arizona and a PhD in Physics from Ludwig-Maximilians-Universität in Munich.